In conclusion, our study sheds light on the impact of LRRK2-mediated neuroinflammation on neurons in a context related to PD and AD and, importantly, suggests that targeting LRRK2 activity could be protective and beneficial for brain disorders with an inflammatory component. Here, LRRK2 is linked to Alzheimer disease.